BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8199039)

  • 1. GATA-1 is expressed in acute erythroblastic leukaemia.
    Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
    Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiation.
    Yamaguchi Y; Zon LI; Ackerman SJ; Yamamoto M; Suda T
    Blood; 1998 Jan; 91(2):450-7. PubMed ID: 9427697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
    Dai W; Murphy MJ
    Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-1 and erythropoietin receptor genes are highly expressed in erythroleukemia.
    Komatsu N; Kirito K; Izumi T; Eguchi M; Miura Y
    Exp Hematol; 1998 Nov; 26(12):1148-54. PubMed ID: 9808054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of GATA-1 mRNA in human myeloid leukemic cells.
    Guerrasio A; Saglio G; Rosso C; Alfarano A; Camaschella C; Lo Coco F; Biondi A; Rambaldi A; Nicolis S; Ottolenghi S
    Leukemia; 1994 Jun; 8(6):1034-8. PubMed ID: 8207977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes.
    Elefanty AG; Antoniou M; Custodio N; Carmo-Fonseca M; Grosveld FG
    EMBO J; 1996 Jan; 15(2):319-33. PubMed ID: 8617207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
    Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW
    Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
    Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
    Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
    Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
    Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
    Linari S; Vannucchi AM; Ciolli S; Leoni F; Caporale R; Grossi A; Pagliai G; Santini V; Paoletti F; Ferrini PR
    Br J Haematol; 1998 Sep; 102(5):1335-7. PubMed ID: 9753066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.
    Patmasiriwat P; Fraizer GC; Claxton D; Kantarjian H; Saunders GF
    Leukemia; 1996 Jul; 10(7):1127-33. PubMed ID: 8683991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proto-oncogene ERG in megakaryoblastic leukemias.
    Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
    Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression pattern of transcription factors (GATA, SCL) and biological characteristics in various leukemia cells].
    Shimamoto T; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1995 Jun; 36(6):547-51. PubMed ID: 7643449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages.
    Martin DI; Zon LI; Mutter G; Orkin SH
    Nature; 1990 Mar; 344(6265):444-7. PubMed ID: 2320112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation.
    Shirihai OS; Gregory T; Yu C; Orkin SH; Weiss MJ
    EMBO J; 2000 Jun; 19(11):2492-502. PubMed ID: 10835348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia.
    Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Kimura N; Nakazawa S; Toyama K
    Leukemia; 1994 Jul; 8(7):1176-80. PubMed ID: 8035609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.